Severe acne can be horrifically debilitating. It leaves sufferers drained of confidence, sometimes even unwilling to leave the house. Case numbers have been growing globally for the past three decades ...

Acne is one of the most common skin conditions seen in general practice. Acne vulgaris – the most prevalent form – affects ...

In this digital age of flawless, perfect, poreless skin, dealing with adult acne can be incredibly isolating. Two skinfluencers and a photographer open up about their acne journeys, the pressure for ...

Isotretinoin, commonly referred to as Accutane, is the only approved medical treatment capable of inducing long-term remission of severe acne. Although highly effective, some individuals experience ...

PARIS — Oral treatment with the novel fatty acid synthase inhibitor denifanstat was associated with significant improvements in moderate-to-severe acne in a phase 3 trial presented at the European ...

Acne vulgaris Researchers examined the relationship between dairy and acne severity and frequency. A significantly lower frequency of acne, as well as lower rates of severe acne, has been reported ...

Oral FASN inhibitors offer a novel mechanism of action for the potential treatment of moderate to severe acne Sagimet initiated first-in-human Phase 1 clinical trial of a second FASN inhibitor, ...

Sagimet initiated first-in-human Phase 1 clinical trial of a second FASN inhibitor, TVB-3567, for development in acne SAN MATEO, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc.

Denifanstat met all endpoints in a Phase 3 acne trial and showed favorable tolerability. Sagimet also launched a Phase 1 trial for TVB-3567. Sagimet Biosciences announced that its oral fatty acid ...

Previous associations between depression, suicidal behavior and the acne drug isotretinoin may be explained by presence of the acne itself, rather than treatment with the medication, according to ...